South San Francisco, CA, United States of America

Frederick Seidl

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 13.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2022)
  • San Mateo, CA (US) (2023)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovative Mind of Frederick Seidl: Revolutionizing Opioid Receptor Modulators

Introduction:

Frederick Seidl, a talented inventor based in South San Francisco, CA, is making waves in the field of pharmaceuticals with his groundbreaking work on opioid receptor modulators. With a portfolio boasting two patents, Seidl is a key player in the development of novel compounds that have the potential to revolutionize pain management.

Latest Patents:

Seidl's latest patents showcase his expertise in the creation of opioid receptor modulators. The first patent focuses on the development of compounds that modulate the mu-opioid receptor (MOR), the kappa-opioid receptor (KOR), and/or the delta-opioid receptor (DOR). The second patent delves into the molecular structure of these compounds and their pharmaceutical compositions, highlighting their potential in the field of medicine.

Career Highlights:

Currently employed at Epiodyne, Inc., Seidl is actively involved in cutting-edge research and development within the company. His contributions to the field have not gone unnoticed, with his patents paving the way for new advancements in opioid receptor modulation. Seidl's dedication to innovation continues to drive the success of Epiodyne, Inc. in the pharmaceutical industry.

Collaborations:

Seidl's work is further enriched by collaborations with esteemed colleagues such as Julio Cesar Medina and Zhi-Liang Wei. Together, they form a dynamic team that collaborates on research projects, shares insights, and collectively pushes the boundaries of scientific discovery. The collaborative spirit within the team undoubtedly contributes to the success of Seidl's innovative endeavors.

Conclusion:

In conclusion, Frederick Seidl stands at the forefront of innovation in the development of opioid receptor modulators. His patented compounds hold immense promise for the future of pain management and pharmaceuticals. With a dedicated focus on advancing scientific knowledge and working collaboratively with his peers, Seidl continues to make significant contributions to the field. Keep an eye on this visionary inventor as he paves the way for groundbreaking advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…